Is sublingual immunotherapy ready for use in the United States?
- PMID: 23532248
- DOI: 10.1001/jama.2013.2739
Is sublingual immunotherapy ready for use in the United States?
Comment on
-
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.JAMA. 2013 Mar 27;309(12):1278-88. doi: 10.1001/jama.2013.2049. JAMA. 2013. PMID: 23532243 Review.
Similar articles
-
Efficacy of sublingual immunotherapy.JAMA. 2013 Aug 14;310(6):644. doi: 10.1001/jama.2013.7643. JAMA. 2013. PMID: 23942686 No abstract available.
-
Efficacy of sublingual immunotherapy.JAMA. 2013 Aug 14;310(6):643-4. doi: 10.1001/jama.2013.7646. JAMA. 2013. PMID: 23942685 No abstract available.
-
Efficacy of sublingual immunotherapy-reply.JAMA. 2013 Aug 14;310(6):644-5. doi: 10.1001/jama.2013.7652. JAMA. 2013. PMID: 23942687 No abstract available.
-
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.JAMA. 2013 Mar 27;309(12):1278-88. doi: 10.1001/jama.2013.2049. JAMA. 2013. PMID: 23532243 Review.
-
Mechanisms of sublingual immunotherapy.J Asthma. 2009 May;46(4):322-34. doi: 10.1080/02770900902785729. J Asthma. 2009. PMID: 19484663 Review.
Cited by
-
The Future of Sublingual Immunotherapy in the United States.Curr Allergy Asthma Rep. 2015 Aug;15(8):44. doi: 10.1007/s11882-015-0545-x. Curr Allergy Asthma Rep. 2015. PMID: 26149585 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
